Fmoc-3-(2-Naphthyl)-L-alanine is a protected amino acid derivative featuring a fluorenylmethyloxycarbonyl (Fmoc) group at the N-terminus and a 2-naphthyl side chain. This compound is a non-natural analog of phenylalanine, where the phenyl ring is replaced by a bulkier naphthalene moiety, enhancing hydrophobic and ж╨-ж╨ stacking interactions. It is primarily utilized as a building block in solid-phase peptide synthesis (SPPS) for constructing peptides with enhanced structural rigidity or biological activity. The naphthyl group is often incorporated into drug candidates targeting protein-protein interactions, GPCRs, or amyloid-related diseases, as it can improve binding affinity and metabolic stability. Additionally, it serves as a key intermediate in the synthesis of pharmaceutical impurities or reference standards for analytical method development. As an Fmoc-protected derivative, it is compatible with standard SPPS protocols and is widely employed in medicinal chemistry research for lead optimization and structure-activity relationship (SAR) studies. Its high purity and defined stereochemistry make it suitable for both academic and industrial drug discovery pipelines.